Genmab A/S (GMAB) Discusses Phase III Cancer Data and Potential New Treatment Standards Transcript
Genmab A/S (GMAB) Discusses Phase III Cancer Data and Potential New Treatment Standards October 28, 2026 12:00 PM EDTCompany ParticipantsJan van de Winkel -...